Nausea and Vomiting, Chemotherapy-Induced Clinical Trial
Official title:
A Phase III Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group Study of the Efficacy and Safety of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonist, Casopitant, Administered in Combination With ZOFRAN and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Subjects Receiving Highly Emetogenic Cisplatin-Based Chemotherapy
This is a Phase III trial designed to demonstrate that casopitant when added to dexamethasone and ondansetron is more effective in the prevention of vomiting then dexamethasone and ondansetron alone, in patients who receive a cisplatin-based highly emetogenic chemotherapy.
A Phase III Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group Study of the Efficacy and Safety of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonist, Casopitant, administered in Combination with ZOFRAN and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Subjects Receiving Highly Emetogenic Cisplatin-Based Chemotherapy ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00404378 -
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
|
Phase 1 | |
| Completed |
NCT00405080 -
A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).
|
Phase 1 | |
| Completed |
NCT00404274 -
A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers
|
Phase 1 | |
| Completed |
NCT00440128 -
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
|
Phase 1 | |
| Completed |
NCT00601172 -
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
|
Phase 3 | |
| Completed |
NCT00511823 -
The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
|
Phase 1 | |
| Completed |
NCT00366834 -
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
|
Phase 3 | |
| Completed |
NCT00437229 -
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
|
Phase 1 | |
| Completed |
NCT00104403 -
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
|
Phase 2 | |
| Completed |
NCT01449188 -
To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects
|
Phase 1 | |
| Terminated |
NCT00334646 -
Cyclophosphamide Drug Interaction Study In Cancer Patients
|
Phase 1 | |
| Completed |
NCT00460707 -
A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults
|
Phase 1 |